BRIEF — SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Oct 15 (Reuters) — SSY Group Ltd: Receives Nmpa China Approval For Sodium Cromoglicate Eye Drops 2% Further company coverage: 2005.HK (Reuters.Briefs@thomsonreuters.com;)
Story updates
10:28:15 AM UTC
SquawkNews
BRIEF – CSPC Pharmaceutical Says SYS6062 Obtains Clinical Trial Approval In China